However, we found that women undergoing insulin therapy had a longer history of previous GDM and a longer family history of diabetes mellitus, which is likely to be related to cumulative damage with each additional pregnancy and the ensuing decrease in the β-cell reserve [23], which would increase not only the risk of re-developing GDM but also the need for insulin therapy to maintain glycemic control. The gene discussed is INS; the disease is gestational diabetes.